We are live on ! Find out more
B

Bailard Portfolio holdings

AUM $4.35B
1-Year Est. Return 23.57%
This Fund
S&P 500
This Quarter Est. Return
+12.46%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$3.38B
AUM Growth
+$357M
Cap. Flow
+$11.3M
Cap. Flow %
0.33%
Top 10 Hldgs %
28.56%
Holding
841
New
147
Increased
207
Reduced
242
Closed
138
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XJH icon
101
iShares ESG Screened S&P Mid-Cap ETF
XJH
$418M
$7.37M 0.22%
195,419
-2,397
-1% -$82.4K
ESML icon
102
iShares ESG Aware MSCI USA Small-Cap ETF
ESML
$2.83B
$7.36M 0.22%
193,701
-4,106
-2% -$140K
IGIB icon
103
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.3B
$7.36M 0.22%
141,445
+28,744
+26% +$1.42M
ROK icon
104
Rockwell Automation
ROK
$51.3B
$7.29M 0.22%
23,466
+596
+3% +$167K
VLO icon
105
Valero Energy
VLO
$90.6B
$7.22M 0.21%
55,566
+552
+1% +$70.2K
NKE icon
106
Nike
NKE
$60.8B
$7.22M 0.21%
66,519
+61,466
+1,216% +$6.6M
BSX icon
107
Boston Scientific
BSX
$64.8B
$7.15M 0.21%
+123,624
New +$6.6M
KO icon
108
Coca-Cola
KO
$349B
$7.11M 0.21%
120,658
+17,664
+17% +$1M
REET icon
109
iShares Global REIT ETF
REET
$5.03B
$7.09M 0.21%
293,077
+9,600
+3% +$210K
DXCM icon
110
DexCom
DXCM
$27.2B
$6.91M 0.2%
55,668
-9,850
-15% -$1.01M
SPSB icon
111
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.4B
$6.82M 0.2%
228,954
+21,027
+10% +$619K
LRCX icon
112
Lam Research
LRCX
$400B
$6.78M 0.2%
86,580
+2,210
+3% +$151K
CMCSA icon
113
Comcast
CMCSA
$78.3B
$6.73M 0.2%
153,491
+379
+0.2% +$16.2K
IGSB icon
114
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.8B
$6.69M 0.2%
130,558
+1,691
+1% +$84.9K
MDT icon
115
Medtronic
MDT
$105B
$6.65M 0.2%
80,708
-1,917
-2% -$146K
CSCO icon
116
Cisco
CSCO
$444B
$6.59M 0.2%
130,483
+8,023
+7% +$410K
VBK icon
117
Vanguard Small-Cap Growth ETF
VBK
$23.4B
$6.53M 0.19%
+26,995
New +$5.86M
XLF icon
118
State Street Financial Select Sector SPDR ETF
XLF
$55.1B
$6.31M 0.19%
167,708
-968
-0.6% -$33.5K
PFE icon
119
Pfizer
PFE
$143B
$6.25M 0.19%
217,195
-4,219
-2% -$128K
PANW icon
120
Palo Alto Networks
PANW
$265B
$6.14M 0.18%
41,670
+220
+0.5% +$29.4K
SCHF icon
121
Schwab International Equity ETF
SCHF
$65.7B
$6.01M 0.18%
325,304
-11,220
-3% -$195K
SPTI icon
122
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
$10.4B
$6.01M 0.18%
210,376
+61,189
+41% +$1.7M
EXPE icon
123
Expedia Group
EXPE
$30.9B
$5.96M 0.18%
39,260
-115
-0.3% -$14.1K
LHX icon
124
L3Harris
LHX
$55.8B
$5.88M 0.17%
27,909
-4,262
-13% -$800K
ASML icon
125
ASML
ASML
$693B
$5.6M 0.17%
7,402
+1
+0% +$660

Similar funds

Bailard's Q4 2023 Portfolio in Review

As of Q4 2023, Bailard held 841 positions worth $3.38B, up 12% from $3.02B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Bailard's Q4 2023 filing shows 147 new, 207 increased, 242 reduced and 138 closed positions. Its largest new stake was Vanguard Tax-Exempt Bond Index Fund: 452,690 shares worth $23.1M. The largest sale was Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF, an estimated $61.4M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • Bailard's largest Q4 2023 buy was Vanguard Tax-Exempt Bond Index Fund: 452,690 shares worth $23.1M.
  • Bailard added most to SPDR Gold Trust in Q4 2023, an estimated $62.8M increase.
  • Bailard's biggest Q4 2023 reduction was Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF, cutting an estimated $61.4M.
  • Bailard fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $5.5M.
  • Bailard's ten largest holdings make up 29% of its $3.38B portfolio in Q4 2023.
  • Bailard opened 147 new positions and closed 138 in Q4 2023.
  • Bailard's portfolio value rose 12% quarter-over-quarter to $3.38B.

Based on Bailard's 13F filing for Q4 2023, filed 2 Feb 2024.